All Phenotypes Rad51<tm1Csha> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Rad51^tm1Csha/Rad51^tm1Csha Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺	involves: 129S/Sv * C57BL/6J	MGI:7311703
cn2	Rad51^tm1Csha/Rad51^tm1Csha Tg(Ddx4-cre)1Dcas/0	involves: C57BL/6J * FVB	MGI:7311694

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

decreased male germ cell number ( J:324159 )

• at P70, no PLZF+ spermatogonial stem cells (SSCs) are detected in the seminiferous tubules of tamoxifen-treated mice

• at P14, no pachytene spermatocytes are detected in the tubules of tamoxifen-treated mice

increased male germ cell apoptosis ( J:324159 )

• at P14 and P70, the number of TUNEL+ apoptotic spermatocytes in the seminiferous tubules of tamoxifen-treated mice is significantly higher than in control males

small testis ( J:324159 )

• at P70, tamoxifen-treated mice show a significantly smaller testis size than control males

decreased testis weight ( J:324159 )

• at P70, testis weight in tamoxifen-treated mice is 80% of that in control males

abnormal spermatogenesis ( J:324159 )

• tamoxifen-treated males exhibit early spermatogenic cells loss and apoptosis

abnormal spermatocyte morphology ( J:324159 )

• at P14, no pachytene spermatocytes are detected in the seminiferous tubules of tamoxifen-treated mice

• at P70, chromosome spreads from tamoxifen-treated testes show a significant decrease in leptotene, zygotene and pachytene spermatocytes with a concomitant increase in diplotene and metaphase I cells relative to control testes

• at P70, % of pachytene spermatocytes is significantly lower than in control testes (12.57% versus 41.37%) whereas % of diplotene spermatocytes is significantly increased (82.74% versus 48.83%)

abnormal male meiosis ( J:324159 )

• at P14, no meiotic cells are found in the testes of tamoxifen-treated mice; only mitotic cells are observed

• no SYCP3+ or gammaH2AX+ cells are observed in the seminiferous tubules of tamoxifen-treated mice at P14

• at P70, chromosome spreads from tamoxifen-treated testes show meiosis defects, including a significant reduction in zygotene and pachytene spermatocytes, defective double-strand DNA repair, and a significant decrease in MLH1 foci in pachytene spermatocytes indicating reduced crossover formation

cellular

abnormal spermatocyte morphology ( J:324159 )

• at P14, no pachytene spermatocytes are detected in the seminiferous tubules of tamoxifen-treated mice

• at P70, % of pachytene spermatocytes is significantly lower than in control testes (12.57% versus 41.37%) whereas % of diplotene spermatocytes is significantly increased (82.74% versus 48.83%)

decreased male germ cell number ( J:324159 )

• at P70, no PLZF+ spermatogonial stem cells (SSCs) are detected in the seminiferous tubules of tamoxifen-treated mice

• at P14, no pachytene spermatocytes are detected in the tubules of tamoxifen-treated mice

abnormal male meiosis ( J:324159 )

• at P14, no meiotic cells are found in the testes of tamoxifen-treated mice; only mitotic cells are observed

• no SYCP3+ or gammaH2AX+ cells are observed in the seminiferous tubules of tamoxifen-treated mice at P14

increased male germ cell apoptosis ( J:324159 )

• at P14 and P70, the number of TUNEL+ apoptotic spermatocytes in the seminiferous tubules of tamoxifen-treated mice is significantly higher than in control males

abnormal double-strand DNA break repair ( J:324159 )

• at P70, chromosome spreads from tamoxifen-treated testes show abnormal accumulation of gammaH2AX foci on the axes of autosomal chromosomes as well as a significant increase of DMC1 foci in pachytene spermatocytes, indicating an increased incidence of unrepaired DNA breaks

homeostasis/metabolism

abnormal double-strand DNA break repair ( J:324159 )

endocrine/exocrine glands

small testis ( J:324159 )

• at P70, tamoxifen-treated mice show a significantly smaller testis size than control males

decreased testis weight ( J:324159 )

• at P70, testis weight in tamoxifen-treated mice is 80% of that in control males

Allelic Composition	Rad51^tm1Csha/Rad51^tm1Csha Tg(Ddx4-cre)1Dcas/0
Genetic Background	involves: C57BL/6J * FVB

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rad51^tm1Csha mutation (0 available); any Rad51 mutation (31 available)
Tg(Ddx4-cre)1Dcas mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

abnormal spermatogonia morphology ( J:324159 )

• at P8, TEM showed complete loss of spermatogonia in seminiferous tubules

decreased male germ cell number ( J:324159 )

• at P12 and P60, Hematoxylin staining of seminiferous tubules showed complete germ cell loss

• at P10, no PLZF+ early spermatogonial stem cells (SSCs) are detected in seminiferous tubules

• however, GCNA+ male germ cells at still present at E18.5

abnormal seminiferous tubule morphology ( J:324159 )

• at P8, testes show severe depletion of germ cells in the seminiferous tubules; only SOX9+ Sertoli cells are detected at P8

increased Sertoli cell number ( J:324159 )

• at P19 and P40, the number of SOX9+ Sertoli cells per tubule is significantly higher than in control testes

small testis ( J:324159 )

• at P40, testis size is significantly smaller than in control males

decreased testis weight ( J:324159 )

• from P10 to P40, testis weight is significantly lower than in control males

• however, testis weight is normal at P8

abnormal spermatogenesis ( J:324159 )

• at P12, seminiferous tubules display complete loss of spermatogonia and a Sertoli cell-only phenotype

• immunofluorescence staining of the Sertoli cell marker SOX9 showed that tubules only contain Sertoli cells at P8

abnormal spermatocyte morphology ( J:324159 )

• at P12, seminiferous tubules show complete loss of leptotene and zygotene spermatocytes

abnormal male meiosis ( J:324159 )

• immunofluorescence staining of meiotic markers showed no SYCP3+ or gammaH2AX+ cells in seminiferous tubules at P8

male infertility ( J:324159 )

• adult male mice mated with wild-type fertile females for at least 6 months produce no pups

cellular

abnormal spermatocyte morphology ( J:324159 )

• at P12, seminiferous tubules show complete loss of leptotene and zygotene spermatocytes

abnormal spermatogonia morphology ( J:324159 )

• at P8, TEM showed complete loss of spermatogonia in seminiferous tubules

decreased male germ cell number ( J:324159 )

• at P12 and P60, Hematoxylin staining of seminiferous tubules showed complete germ cell loss

• at P10, no PLZF+ early spermatogonial stem cells (SSCs) are detected in seminiferous tubules

• however, GCNA+ male germ cells at still present at E18.5

abnormal male meiosis ( J:324159 )

• immunofluorescence staining of meiotic markers showed no SYCP3+ or gammaH2AX+ cells in seminiferous tubules at P8

endocrine/exocrine glands

abnormal seminiferous tubule morphology ( J:324159 )

• at P8, testes show severe depletion of germ cells in the seminiferous tubules; only SOX9+ Sertoli cells are detected at P8

increased Sertoli cell number ( J:324159 )

• at P19 and P40, the number of SOX9+ Sertoli cells per tubule is significantly higher than in control testes

small testis ( J:324159 )

• at P40, testis size is significantly smaller than in control males

decreased testis weight ( J:324159 )

• from P10 to P40, testis weight is significantly lower than in control males

• however, testis weight is normal at P8

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/30/2024 MGI 6.23